Testis-specific basic protein Y 2 (BPY2)

Testis-specific basic protein Y 2 (BPY2) is encoded by the BPY2 gene, located on the male-specific (nonrecombining) portion of the Y chromosome. The protein is expressed exclusively in testis, with strong evidence for a role in male germ cell development and implicated in the pathogenesis of male infertility. BPY2 forms a winged helix–turn–helix (HTH)-like domain, likely mediating DNA or RNA binding, and interacts with the ubiquitin protein ligase E3A (UBE3A), suggesting a role in ubiquitination-dependent regulation. There are three nearly identical copies of BPY2 on the Y chromosome; two are within a palindromic region. Deletion or dysregulation of BPY2 has been associated with azoospermia (absence of sperm), male infertility, and may play a role as a cancer biomarker, particularly in seminoma and hepatocellular carcinoma, though its function as a therapeutic target is not established[1][2][3][4][5][6][7]. Key notes: - BPY2 is not considered a traditional therapeutic target such as a receptor, enzyme, transporter, or transcription factor; it is a testis-specific nuclear protein involved in male germ cell biology[2][5][6][7]. - There are no known drugs that interact directly with BPY2, and no described mechanism of pharmacological action. - Known safety/clinical interest is restricted to genetic deletion or deficiency, which is linked to infertility. - BPY2 is sometimes referred to by multiple aliases, reflecting its copy number (BPY2A, VCY2, etc.) and function; however, the canonical nomenclature is "Testis-specific basic protein Y 2 (BPY2)." - Potential novel biomarker usage in oncology is based on limited and preliminary data[4].

Other names

BPY2AVCY2VCY2AVCY2BVCY2Cbasic charge, Y-linked 2variably charged protein Y 2basic protein on Y chromosome 2testis-specific basic protein on Y 2basic charge, Y-linked, 2VCY2_HUMAN